The immunotherapy OST-HER2 combined with palliative radiation has shown positive data in preventing or delaying amputation ...

Tumors develop when cells in the body grow uncontrollably. Finding a tumor on your dog can be very frightening, but they are ...

Yet to be published data from clinical study combining OST-HER2 with palliative radiation in dogs with unresected, primary osteosarcoma shows clinical and radiographic arrest of the primary tumor ...

"Comparative oncology is an important area of research for us because of the striking genetic homology of over 96% between human and canine osteosarcoma." OST-HER2 is an investigational drug and ...

As someone that wholly embraces cancer immunotherapy, I believe their recent USDA license for canine osteosarcoma represents the first of many ELIAS-led advancements to come in veterinary cancer ...

OS Therapies (OSTX) announced data in the prevention or delay of amputation during the treatment of primary osteosarcoma for OST-HER2 combined ...

New unpublished research shows that when combined with palliative radiation, OST-HER2 has had a significant impact on dogs with unresected, primary osteosarcoma. Out of 15 dogs treated ...